Skip to main content

James Kramer, Cyndi Tolman

Premium

Serologicals has hired James Kramer as vice president of global manufacturing operations, and has appointed Cyndi Tolman managing director of plasma operations, the company said last week.

Kramer will report directly to David Dodd, president and CEO. He will be responsible for the production and supply chain related to plasma operations and the manufacturing operations in Kankakee, Ill.; Toronto; Milford, Mass.; Gaithersburg, Md.; and Livingston, UK. Previously, Kramer was vice president of plasma operations.

Tolman, who reports directly to Kramer, will be responsible for all activities within plasma operations. She joined Serologicals in 1990 as executive director of the Columbia, SC, donor center.

Filed under

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.